Literature DB >> 6322828

Comparison between the effects of inhaled isoprenaline and fenoterol on plasma cyclic AMP and heart rate in normal subjects.

A J Fairfax, M Rehahn, D Jones, B O'Malley.   

Abstract

The time course of changes in plasma cyclic AMP, heart rate and bronchial tone after inhalation of fenoterol or isoprenaline from a dose-metered aerosol are reported in a group of normal subjects. After isoprenaline, plasma cyclic AMP increased rapidly reaching a peak by 10 min and returned to basal levels within 60 min. A rapid, transient rise in heart rate occurred that was maximal by 5 min and returned to a basal level by 45 min. After fenoterol, the changes in cyclic AMP and heart rate were of much longer duration. The rise in plasma cyclic AMP was slower in onset and of greater magnitude than for isoprenaline, reaching a peak by 20 min and remaining above basal level for more than 6 h. The maximum increase in heart rate after fenoterol was less than that observed with isoprenaline but an elevated rate persisted for 4 h after inhalation of fenoterol. Fenoterol is known to have a longer duration of action as a bronchodilator in comparison with isoprenaline. The prolonged rise in plasma cyclic AMP in normal subjects given inhaled fenoterol may reflect this long duration of action. The concomitant rise in heart rate, however, suggests that the duration of plasma cyclic AMP response may in part be due to the systemic effect of the fraction of inhaled fenoterol known to be absorbed via the buccal and intestinal routes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6322828      PMCID: PMC1463317          DOI: 10.1111/j.1365-2125.1984.tb02332.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  30 in total

1.  Decreased urinary adenosine 3',5' monophosphate (cyclic AMP) in asthmatics.

Authors:  R A Bernstein; L Linarelli; M A Facktor; G A Friday; A L Drash; P Fireman
Journal:  J Lab Clin Med       Date:  1972-12

Review 2.  Studies on the mechanism of hormone action.

Authors:  E W Sutherland
Journal:  Science       Date:  1972-08-04       Impact factor: 47.728

3.  Cyclic adenosine 3',5'-monophosphate in human lung.

Authors:  M A Kaliner; R P Orange; W J Koopman; K F Austen; P J Laraia
Journal:  Biochim Biophys Acta       Date:  1971-10

Review 4.  Extracellular cyclic nucleotides.

Authors:  A E Broadus; J G Hardman; N I Kaminsky; J H Ball; E W Sutherland; G W Liddle
Journal:  Ann N Y Acad Sci       Date:  1971-12-30       Impact factor: 5.691

5.  Some bronchoconstricting and bronchodilating responses of human isolated bronchi: evidence for the existence of -adrenoceptors.

Authors:  A A Mathé; A Aström; N A Persson
Journal:  J Pharm Pharmacol       Date:  1971-12       Impact factor: 3.765

6.  Metabolism of isoprenaline and other bronchodilator drugs in man and dog.

Authors:  D S Davies
Journal:  Bull Physiopathol Respir (Nancy)       Date:  1972 May-Jun

7.  Isoproterenol aerosol in normal and asthmatic subjects. Time relationship of pulmonary and hemodynamic responses.

Authors:  R N Pierson; M H Grieco
Journal:  Am Rev Respir Dis       Date:  1969-10

8.  Histamine release in vitro: inhibition by catecholamines and methylxanthines.

Authors:  L M Lichtenstein; S Margolis
Journal:  Science       Date:  1968-08-30       Impact factor: 47.728

9.  Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents.

Authors:  C W Parker; J W Smith
Journal:  J Clin Invest       Date:  1973-01       Impact factor: 14.808

10.  Kinetic parameters and renal clearances of plasma adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate in man.

Authors:  A E Broadus; N I Kaminsky; J G Hardman; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

View more
  2 in total

1.  Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers.

Authors:  M Scheinin; M Koulu; E Laurikainen; H Allonen
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

2.  Pharmacological effects and pharmacokinetics of atipamezole, a novel alpha 2-adrenoceptor antagonist--a randomized, double-blind cross-over study in healthy male volunteers.

Authors:  S Karhuvaara; A Kallio; M Scheinin; M Anttila; J S Salonen; H Scheinin
Journal:  Br J Clin Pharmacol       Date:  1990-07       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.